File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Long-term outcome in patients with chronic atrial fibrillation after successful internal cardioversion

TitleLong-term outcome in patients with chronic atrial fibrillation after successful internal cardioversion
Authors
Tse, HFLau, CPAyers, GM
Issue Date1999
PublisherExcerpta Medica, Inc.. The Journal's web site is located at http://www.ajconline.org/
Citation
American Journal Of Cardiology, 1999, v. 83 n. 4, p. 607-609 How to Cite?
DOI: http://dx.doi.org/10.1016/S0002-9149(98)00925-4
AbstractInternal cardioversion is safe and effective in restoring sinus rhythm, even in patients with persistent AF of prolonged duration. Up to 40% to 50% of patients with AF lasting ≥1 year but ≤3 years could be maintained in sinus rhythm using a class III antiarrhythmic drag after successful internal cardioversion, and amiodarone appears to be more effective than sotalol in this patient population.
Persistent Identifierhttp://hdl.handle.net/10722/162362
ISSN
0002-9149
2023 Impact Factor: 2.3
2023 SCImago Journal Rankings: 0.950
ISI Accession Number ID
WOS:000078573200028
References
References in Scopus

 

DC FieldValueLanguage
dc.contributor.authorTse, HFen_US
dc.contributor.authorLau, CPen_US
dc.contributor.authorAyers, GMen_US
dc.date.accessioned2012-09-05T05:19:17Z-
dc.date.available2012-09-05T05:19:17Z-
dc.date.issued1999en_US
dc.identifier.citationAmerican Journal Of Cardiology, 1999, v. 83 n. 4, p. 607-609en_US
dc.identifier.issn0002-9149en_US
dc.identifier.urihttp://hdl.handle.net/10722/162362-
dc.description.abstractInternal cardioversion is safe and effective in restoring sinus rhythm, even in patients with persistent AF of prolonged duration. Up to 40% to 50% of patients with AF lasting ≥1 year but ≤3 years could be maintained in sinus rhythm using a class III antiarrhythmic drag after successful internal cardioversion, and amiodarone appears to be more effective than sotalol in this patient population.en_US
dc.languageengen_US
dc.publisherExcerpta Medica, Inc.. The Journal's web site is located at http://www.ajconline.org/en_US
dc.relation.ispartofAmerican Journal of Cardiologyen_US
dc.subject.meshAgeden_US
dc.subject.meshAmiodarone - Therapeutic Useen_US
dc.subject.meshAnti-Arrhythmia Agents - Therapeutic Useen_US
dc.subject.meshAtrial Fibrillation - Therapyen_US
dc.subject.meshChronic Diseaseen_US
dc.subject.meshElectric Countershocken_US
dc.subject.meshFemaleen_US
dc.subject.meshHumansen_US
dc.subject.meshMaleen_US
dc.subject.meshMiddle Ageden_US
dc.subject.meshProspective Studiesen_US
dc.subject.meshSotalol - Therapeutic Useen_US
dc.subject.meshTreatment Outcomeen_US
dc.titleLong-term outcome in patients with chronic atrial fibrillation after successful internal cardioversionen_US
dc.typeArticleen_US
dc.identifier.emailTse, HF:hftse@hkucc.hku.hken_US
dc.identifier.authorityTse, HF=rp00428en_US
dc.description.naturelink_to_subscribed_fulltexten_US
dc.identifier.doi10.1016/S0002-9149(98)00925-4en_US
dc.identifier.pmid10073873-
dc.identifier.scopuseid_2-s2.0-0033557893en_US
dc.identifier.hkuros41422-
dc.relation.referenceshttp://www.scopus.com/mlt/select.url?eid=2-s2.0-0033557893&selection=ref&src=s&origin=recordpageen_US
dc.identifier.volume83en_US
dc.identifier.issue4en_US
dc.identifier.spage607en_US
dc.identifier.epage609en_US
dc.identifier.isiWOS:000078573200028-
dc.publisher.placeUnited Statesen_US
dc.identifier.scopusauthoridTse, HF=7006070805en_US
dc.identifier.scopusauthoridLau, CP=7401968501en_US
dc.identifier.scopusauthoridAyers, GM=7102015157en_US
dc.identifier.issnl0002-9149-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats